The role of opioid receptor subtypes in the development of behavioral sensitization to ethanol

Raúl Pastor1, Carlos M G Aragon

  • 1Area de Psicobiología, Universitat Jaume I, Castelló, Spain.

Insights

Blocking mu opioid receptors is key to preventing ethanol-induced behavioral sensitization in mice. This suggests that targeting all mu opioid receptor subtypes is necessary to block neural adaptations related to ethanol sensitization.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • Opioid receptors play a role in behavioral sensitization to ethanol.
  • The specific opioid receptor subtypes involved are not fully understood.

Purpose of the Study:

  • To investigate the role of specific opioid receptor subtypes in ethanol-induced locomotor sensitization in mice.
  • To determine if mu, delta, or specific mu subtypes are responsible for this effect.

Main Methods:

  • Mice were administered ethanol (2.5 g/kg/day for six sessions) to induce locomotor sensitization.
  • Various opioid receptor antagonists were used: naltrexone (nonspecific), CTOP (mu-selective), naltrindole (delta-selective), naloxonazine (mu(1)-selective), and 3-methoxynaltrexone (mu(3)-selective).
  • Locomotor activity was measured to assess sensitization.

Main Results:

  • Nonspecific opioid receptor blockade with naltrexone prevented ethanol sensitization.
  • Selective mu opioid receptor antagonist CTOP also blocked sensitization.
  • Selective delta receptor antagonist naltrindole had no effect on sensitization.
  • Blockade of mu(1) or mu(3) receptors alone did not prevent sensitization.
  • Blocking mu(1+2) receptor subtypes with naloxonazine retarded sensitization.

Conclusions:

  • Concurrent inactivation of all mu opioid receptor subtypes may be required to prevent neural adaptations underlying ethanol sensitization.
  • These findings support a role for the mu opioid receptor and beta-endorphin in ethanol sensitization.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...